The British Journal of Cancer is a twice-monthly professional medical journal owned by Cancer Research UK, published on their behalf by Springer Nature's Nature Research.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 45.3 as reported by Clarivate in its 2022 Journal Citation Reports.
Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of tumors. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:
JCO Oncology Practice is a monthly peer-reviewed medical journal covering the mechanics of oncology care. It was established in 2005 and is published by the American Society of Clinical Oncology. The editor-in-chief is John V. Cox. The editor-in-chief designate is Jeffrey Peppercorn.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology. Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in cancer etiology and prevention. It is published by the American Association for Cancer Research and co-sponsored by the American Society of Preventive Oncology.
The European Journal of Cancer is a peer-reviewed medical journal devoted to cancer research on experimental oncology, clinical oncology, and on cancer epidemiology and prevention. It is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA). The editor-in-chief is Alexander M. M. Eggermont.
Gynecologic Oncology is a peer-reviewed medical journal covering all aspects of gynecologic oncology. The journal covers investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest. It is published by Elsevier and is the official journal of the Society of Gynecologic Oncology.
The American Journal of Clinical Oncology is a bimonthly, peer-reviewed, scientific, oncology journal, published by Lippincott Williams & Wilkins. The editor in chief is David E. Wazer. The journal was formerly entitled Cancer Clinical Trials.
Dr. Dattatreyudu Nori is a noted Indian radiation oncologist. He was once named one of the top doctors in America for the treatment of cancers in women by the women's magazine Ladies' Home Journal.
Dr. Kodaganur S. Gopinath, MS, FAMS, FRCS (Edin) is an Indian surgical oncologist, known for his pioneering work on oncological research. He is a recipient of many awards including Dr. B. C. Roy Award, considered to be the premier medical honour in the country. The President of India recognised his services to the field of oncology, by awarding him the fourth highest civilian award, Padma Shri, in 2010.
Rajendra Achyut Badwe, is an Indian medical doctor and surgical oncologist. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine. He is currently the Director of Tata Memorial Centre.
Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.
Dr. Jitendra Kumar Singh is an Indian oncologist, the ex director of Mahavir Cancer Institute & Research Centre and the president of Cancer Care India, the apex body for cancer support organisations in India. He was honoured by the Government of India, in 2012, with the fourth highest Indian civilian award of Padma Shri.
Luis Jose De Souza is an Indian surgical oncologist and the founder of Shanti Avedna Ashram, a charitable trust which runs a network of hospices in Mumbai and Goa. He has also contributed to the establishment of Indian Cancer Cell, an educational program co-sponsored by Tata Memorial Centre, Union for International Cancer Control (UICC) and Indian Cancer Society, for creating cancer awareness in schools. The Government of India awarded him the fourth-highest civilian honour of the Padma Shri in 1992.
Ashok K. Vaid is an Indian medical oncologist, known for his pioneering efforts in bone marrow transplantation in India. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India. He heads the Cancer Institute- Division of Medical Oncology and Haemotology at Medanta The Medicity.
Darab Jehangir Jussawala (1915–1999) was an Indian medical-cum-surgical oncologist, medical writer and the director of Tata Memorial Centre. He was the co-founder of Indian Cancer Society, along with Naval Tata in 1951, and the founder of the Indian Cancer Rehabilitation Centre in Parel, Mumbai, in 1956, the first such centre in India and the largest in Asia. He served as the director of Lady Ratan Tata Medical and Research Center and as the honorary consultant at two Mumbai hospitals, Breach Candy Hospital and Jaslok Hospital. An elected fellow of the Royal Society of Medicine, National Academy of Medical Sciences, Indian Academy of Sciences, Indian National Science Academy and the American College of Surgeons, he was a recipient of the Dhanwantari Award as well as several Oration Awards. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 1975, for his contributions to Medicine.
Prafulla B. Ragubhai Desai is an Indian surgical oncologist and a former chairman of the Research Advisory Committee on Oncology of the Indian Council of Medical Research. He is credited with the first bone marrow transplantation in India, which he performed with his team in 1983. He is a former director and superintendent at Tata Memorial Centre, Mumbai (1973–1995) and continues his association with the institution as their professor emeritus. He is one of the founders of the Rural Cancer Centre established by Tata Memorial Centre at Barshi, Mumbai and serves Breach Candy Hospital as a surgical oncologist and the Indo-Global Summit on Head and Neck Oncology (IGSHNO) as a member of their national faculty.
The Cancer Institute , also known as the Adyar Cancer Institute, is a non-profit cancer treatment and research centre based in Chennai, Tamil Nadu. The Cancer Institute (WIA) was established in the year 1952 under the leadership of Muthulakshmi Reddy. In 1974, the institute became the Regional Cancer Centre and declared a Centre of Excellence"by the Ministry of Health and Family Welfare.
